Birds Eye View Technical Analysis forInnoviva, Inc. (NASDAQ:INVA)

98

Technical Indicators and Signals

The stochastic oscillator indicator is the important indicator to compare the security price over a certain period of time. The stochastic %K of Innoviva, Inc. (NASDAQ:INVA) for the period of 9-Day stands at 23.47% while the stochastic %D for the same period stands at 20.27%.

The 7-Day Average Directional Index ADX (also known as Trend Strength Indicator) of Innoviva, Inc. (NASDAQ:INVA) signals “Sell” while other important signals like the 20-Day Moving Average Vs. Price signals “Sell”.

Another important signal of trend and momentum of a security is 20-50 Day MACD Oscillator or Moving Average Convergence Divergence signals “Buy” for Innoviva, Inc. (NASDAQ:INVA) while 20-100 Day MACD Oscillator indicates “Buy”.

Bollinger band is a volatility indicator of a certain security, currently Innoviva, Inc. (NASDAQ:INVA)’s 20-Day Bollinger Band indicates “Hold”.

About Company

Innoviva, Inc. is focused on the development, commercialization and financial management of bio-pharmaceuticals. The company’s portfolio of respiratory assets partnered with Glaxo Group Limited, including RELVAR(R)/BREO(R) ELLIPTA(R) and ANORO(R) ELLIPTA(R). Innoviva, Inc., formerly known as Theravance, Inc., is headquartered in South San Francisco, California.

Previous Day Activity Analysis

On the last trading day, Innoviva, Inc. (NASDAQ:INVA) opened the session at $14 and after going down -0.43% closed at $13.93. The stock lost -0.07 points in the last trade.

Innoviva, Inc. (NASDAQ:INVA)’s stock fluctuated in the range of $13.86 and $14.21 during the previous active session. Innoviva, Inc. (NASDAQ:INVA) traded with the volume of 932513 with average volume of 1 Million. The stock has MEDIUM volatility on the last trading session.

Currently the Beta for the company remains at 2.58 while ATR (Average True Range) and RSI (Relative Strength Index) are at 0.37 and 52.9 respectively.

Currently the Insider Ownership of the shares of Innoviva, Inc. (NASDAQ:INVA) is at 2.4% and the shares outstanding are 110.47 Million.

Important Ratio Analysis

Some important ratios to consider here for Innoviva, Inc. (NASDAQ:INVA) are discussed below:

Dividend yield of Innoviva, Inc. (NASDAQ:INVA) stands at 0% whereas Price to Earnings P/E ratio stands at 19.46 while Forward P/E shows the value of 7.77.

The PEG ratio (Price to Earning to Growth) emits the value of 0.39. The Price to Sale P/S and Price to Book P/B shows the value of 8.74 and 0 respectively. While Price to Cash P/C and Price to Free Cash Flow P/FCF stands at 11.35 and 0 correspondingly.

The Quick Ratio of Innoviva, Inc. (NASDAQ:INVA) stands at 7.3 while the Current Ratio depicts the value of 7.3.

Return on Assets ROA of Innoviva, Inc. (NASDAQ:INVA) is at 24.4% whereas, Return on Equity ROE and Return of Investment ROI of Innoviva, Inc. (NASDAQ:INVA) stand at -27.4% and 30% respectively.

Stock Performance Analysis

The stock performance of Innoviva, Inc. (NASDAQ:INVA) on the basis of 5 day trade show the dip of -0.07% whereas, the monthly performance of the stock shows increase of 0.87%.

The quarterly performance of the stock remained in green zone with the value of 6.99% while six month performance of the shares of Innoviva, Inc. (NASDAQ:INVA) remained bearish with the count of -0.64%.

The yearly and YTD performance of Innoviva, Inc. (NASDAQ:INVA) remained up at 39.58% and 30.19% respectively.